Call Options

29 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $4.76 Million - $6.21 Million
120,000 Added 17.27%
814,700 $42.2 Million
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $6.7 Million - $8.82 Million
-166,500 Reduced 19.33%
694,700 $28.9 Million
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $48.6 Million - $55.1 Million
-1,013,200 Reduced 54.05%
861,200 $46.7 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $50.1 Million - $59.8 Million
-1,033,700 Reduced 35.55%
1,874,400 $96.2 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $22.7 Million - $25.4 Million
392,600 Added 15.61%
2,908,100 $169 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $16.8 Million - $18.7 Million
263,800 Added 11.72%
2,515,500 $161 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $15.2 Million - $17.2 Million
-231,200 Reduced 9.31%
2,251,700 $156 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $87.3 Million - $103 Million
1,274,800 Added 105.52%
2,482,900 $179 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $47,749 - $28.2 Million
-367,300 Reduced 23.31%
1,208,100 $85.9 Million
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $30.2 Million - $33.3 Million
415,900 Added 35.87%
1,575,400 $121 Million
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $23.9 Million - $28.7 Million
388,800 Added 50.45%
1,159,500 $84.7 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $32.9 Million - $38.3 Million
612,600 Added 387.48%
770,700 $48.1 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $2 Million - $2.34 Million
-33,800 Reduced 17.61%
158,100 $9.36 Million
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $5.8 Million - $6.32 Million
93,700 Added 95.42%
191,900 $12.8 Million
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $26.1 Million - $29.3 Million
-439,200 Reduced 81.73%
98,200 $6.2 Million
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $10.3 Million - $11.6 Million
-177,600 Reduced 24.84%
537,400 $33.3 Million
Q3 2020

Nov 16, 2020

BUY
$57.43 - $63.64 $1.34 Million - $1.49 Million
23,400 Added 3.38%
715,000 $43.1 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $17.9 Million - $21 Million
-327,100 Reduced 32.11%
691,600 $40.7 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $1.63 Million - $2.37 Million
-35,200 Reduced 3.34%
1,018,700 $56.8 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $19.6 Million - $25.6 Million
399,300 Added 61.0%
1,053,900 $67.7 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $15.9 Million - $18.9 Million
372,800 Added 132.29%
654,600 $33.2 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $35 Million - $38.7 Million
-785,300 Reduced 73.59%
281,800 $12.8 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $35.3 Million - $42.1 Million
783,100 Added 275.74%
1,067,100 $50.9 Million
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $4.83 Million - $6.26 Million
-99,000 Reduced 25.85%
284,000 $14.8 Million
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $7.37 Million - $8.32 Million
133,600 Added 53.57%
383,000 $23.8 Million
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $2.5 Million - $3.11 Million
49,400 Added 24.7%
249,400 $13.8 Million
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $6.21 Million - $7.15 Million
-103,600 Reduced 34.12%
200,000 $12.7 Million
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $17,982 - $19,605
300 Added 0.1%
303,600 $18.6 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $16.8 Million - $19.3 Million
303,300
303,300 $19.3 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.